Aristotle Atlantic Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,600
| Closed | -$220K | – | 86 |
|
|
2025
Q1 | $220K | Hold |
3,600
| – | – | 0.01% | 88 |
|
|
2024
Q4 | $204K | Buy |
+3,600
| New | +$204K | 0.01% | 90 |
|
|
2023
Q4 | – | Sell |
-226,267
| Closed | -$13.1M | – | 97 |
|
|
2023
Q3 | $13.1M | Sell |
226,267
-5,491
| -2% | -$319K | 0.53% | 57 |
|
|
2023
Q2 | $14.8M | Buy |
231,758
+57,033
| +33% | +$3.65M | 0.56% | 55 |
|
|
2023
Q1 | $12.1M | Buy |
174,725
+981
| +0.6% | +$68K | 0.62% | 55 |
|
|
2022
Q4 | $12.5M | Buy |
173,744
+669
| +0.4% | +$48.1K | 0.7% | 47 |
|
|
2022
Q3 | $12.3M | Buy |
173,075
+1,281
| +0.7% | +$91.1K | 0.75% | 46 |
|
|
2022
Q2 | $13.2M | Buy |
171,794
+33,684
| +24% | +$2.59M | 1.02% | 27 |
|
|
2022
Q1 | $10.1M | Buy |
138,110
+3,680
| +3% | +$269K | 0.62% | 40 |
|
|
2021
Q4 | $8.38M | Sell |
134,430
-31,655
| -19% | -$1.97M | 0.49% | 49 |
|
|
2021
Q3 | $9.83M | Buy |
166,085
+2,336
| +1% | +$138K | 0.65% | 38 |
|
|
2021
Q2 | $10.9M | Buy |
163,749
+3,257
| +2% | +$218K | 0.72% | 35 |
|
|
2021
Q1 | $10.1M | Buy |
160,492
+32,559
| +25% | +$2.06M | 0.74% | 37 |
|
|
2020
Q4 | $7.94M | Buy |
127,933
+964
| +0.8% | +$59.8K | 0.61% | 39 |
|
|
2020
Q3 | $7.66M | Buy |
126,969
+1,006
| +0.8% | +$60.7K | 0.67% | 37 |
|
|
2020
Q2 | $7.41M | Buy |
125,963
+3,419
| +3% | +$201K | 0.71% | 36 |
|
|
2020
Q1 | $6.83M | Buy |
122,544
+760
| +0.6% | +$42.4K | 1.04% | 31 |
|
|
2019
Q4 | $7.82M | Buy |
+121,784
| New | +$7.82M | 1% | 33 |
|
|
2018
Q4 | – | Sell |
-3,600
| Closed | -$223K | – | 88 |
|
|
2018
Q3 | $223K | Buy |
+3,600
| New | +$223K | 0.14% | 41 |
|
|
2018
Q2 | – | Sell |
-3,600
| Closed | -$228K | – | 85 |
|
|
2018
Q1 | $228K | Hold |
3,600
| – | – | 0.08% | 84 |
|
|
2017
Q4 | $221K | Buy |
+3,600
| New | +$221K | 0.08% | 81 |
|